Tag: Cancer

Researcher uses machine learning to demonstrate that DNA impacts cancer risk

DNA
DNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIH

Lifestyle—or put another way, ‘bad habits’—is one of the textbook explanations for why some people are at higher risk for cancer. We often hear that smoking increases our risk of developing lung cancer or that a high-fat diet increases our risk of developing bowel cancer, but not all smokers get lung cancer and not all people who eat cheeseburgers get bowel cancer. ‘Other factors’ must be at play.

Now, new research from University of Calgary scientist Dr. Edwin Wang, Ph.D., is shedding light on those

Read More

Nudges combined with machine learning triples advanced care conversations among patients with cancer

patient
Credit: Unsplash/CC0 Public Domain

An electronic nudge to clinicians—triggered by an algorithm that used machine learning methods to flag patients with cancer who would most benefit from a conversation around end-of-life goals—tripled the rate of those discussions, according to a new prospective, randomized study of nearly 15,000 patients from Penn Medicine and published today in JAMA Oncology.

Early and frequent conversations with patients suffering from serious illness, particularly cancer, have been shown to increase satisfaction, quality of life, and care that’s consistent with their values and goals. However, today many do not get the opportunity to have those discussions

Read More

FDA-ASCO PUBLIC WORKSHOP: 2020 Clinical Outcome Assessments in Cancer Clinical Trials Fifth Annual Workshop – 07/22/2020 – 07/17/2020



Twitter: #OCEOutcomes20 

Co-Sponsor: American Society of Clinical Oncology (ASCO)

Co-Chairs:

  • U.S. Food and Drug Administration
    • Paul Kluetz, MD
      Deputy Director, Oncology Center of Excellence, FDA
       
  • American Society of Clinical Oncology
    • Kathryn F. Mileham, MD, FACP
      Chair, Cancer Research Committee, ASCO
       
    • Heidi Klepin, MD, MS
      Immediate Past Chair, Cancer Research Committee, ASCO
       
      Date: July 17, 2020 (Friday)
      Time: 9:00 am to 4:00 pm

Pre-Workshop Introduction Video

Please watch this video prior to the workshop, in which the co-chairs discuss the context and background for this year’s event.

Background

Since the first COA-CCT meeting in 2015, our overarching goal

Read More

FDA-ASCO PUBLIC WORKSHOP: 2020 Clinical Outcome Assessments in Cancer Clinical Trials Fifth Annual Workshop – 07/17/2020 – 07/17/2020




Twitter: #OCEOutcomes20 

Co-Sponsor: American Society of Clinical Oncology (ASCO)

Co-Chairs:

  • U.S. Food and Drug Administration
    • Paul Kluetz, MD
      Deputy Director, Oncology Center of Excellence, FDA
       
  • American Society of Clinical Oncology
    • Kathryn F. Mileham, MD, FACP
      Chair, Cancer Research Committee, ASCO
       
    • Heidi Klepin, MD, MS
      Immediate Past Chair, Cancer Research Committee, ASCO
       
      Date: July 17, 2020 (Friday)
      Time: 9:00 am to 4:00 pm

Pre-Workshop Introduction Video

Please watch this video prior to the workshop, in which the co-chairs discuss the context and background for this year’s event.

Webcast Information

  • Link will be added 2 days before workshop

Background

Read More